FeedworthyAI
Back to feed
GEN – Genetic Engineering and Biotechnology Newsnews

Transcripta Bio Raises $24M for AI-Driven Neurological Disease Therapies

Wednesday, July 22, 2026Fay Lin, PhDView original

The Palo Alto-based company is developing small molecule drugs that modulate the transcriptome. The latest funding raise will advance IND-enabling studies and clinical preparation of its neurological disease portfolio.

The post Transcripta Bio Raises $24M for AI-Driven Neurological Disease Therapies appeared first on GEN - Genetic Engineering and Biotechnology News.